SEC Form 4 · accession 0001209191-16-149393
Orthofix Medical Inc. · OFIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brad Mason
Officer — CEO
Period of report
Nov 8, 2016
Accepted (ET)
Nov 10, 2016 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Nov 8, 2016 | S | 5,000 | $36.8145 | D | 151,219 | D | |
| Common StockF3 | Nov 10, 2016 | S | 4,538 | $36.8432 | D | 146,681 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of the shares reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on September 15, 2016.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $36.63, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.56 to $36.41, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.